Abstract

Gestational complications, including preeclampsia and gestational diabetes, have long-term adverse consequences for offspring’s metabolic and cardiovascular health. A low-grade systemic inflammatory response is likely mediating this. Here, we examine the consequences of LPS-induced gestational inflammation on offspring’s health in adulthood. LPS was administered to pregnant C57Bl/6J mice on gestational day 10.5. Maternal plasma metabolomics showed oxidative stress, remaining for at least 5 days after LPS administration, likely mediating the consequences for the offspring. From weaning on, all offspring was fed a control diet; from 12 to 24 weeks of age, half of the offspring received a western-style diet (WSD). The combination of LPS-exposure and WSD resulted in hyperphagia and increased body weight and body fat mass in the female offspring. This was accompanied by changes in glucose tolerance, leptin and insulin levels and gene expression in liver and adipose tissue. In the hypothalamus, expression of genes involved in food intake regulation was slightly changed. We speculate that altered food intake behaviour is a result of dysregulation of hypothalamic signalling. Our results add to understanding of how maternal inflammation can mediate long-term health consequences for the offspring. This is relevant to many gestational complications with a pro-inflammatory reaction in place.

Details

Title
Mid-gestation low-dose LPS administration results in female-specific excessive weight gain upon a western style diet in mouse offspring
Author
Dijkstra, Dorieke J 1 ; Verkaik-Schakel Rikst Nynke 1 ; Eskandar, Sharon 2 ; Limonciel Alice 3 ; Stojanovska Violeta 4 ; Scherjon, Sicco A 1 ; Plösch Torsten 5 

 University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynaecology, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598) 
 University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynaecology, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598); University of Groningen, University Medical Center Groningen, Section Molecular Neurobiology, Department of Biomedical Sciences of Cells and Systems, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598) 
 Biocrates Life Sciences AG, Innsbruck, Austria (GRID:grid.431833.e) (ISNI:0000 0004 0521 4243) 
 Helmholtz Centre for Environmental Research, Department of Environmental Immunology, Leipzig, Germany (GRID:grid.7492.8) (ISNI:0000 0004 0492 3830) 
 University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynaecology, Groningen, The Netherlands (GRID:grid.4494.d) (ISNI:0000 0000 9558 4598); School of Medicine and Health Sciences Carl von Ossietzky University Oldenburg, Perinatal Neurobiology, Department of Human Medicine, Oldenburg, Germany (GRID:grid.5560.6) (ISNI:0000 0001 1009 3608) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471560480
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.